Association of Oxidative Stress Index With Disease Control During Omalizumab-Based Treatment in Antihistamine-Refractory Chronic Spontaneous Urticaria: A Prospective Observational Study.
Findings indicate that on-treatment OSI was associated with concurrent disease control and that within-person OSI change paralleled change in UCT, and that within-person OSI change paralleled change in UCT.